212,599 profiles ranked

Tasuku Honjo

Japanese professor of immunology and genomic medicine (1942-) · Japan · Academics

Tasuku Honjo is read about 400 times a day, in 54 languages.

A typical day, 30 days to 23 October 2026

The middle day of the days counted, so one week of news cannot move it. The line under it is the last 398 days, one point a day.

Something wrong?
Compare Claim

Tasuku Honjo is a Japanese physician-scientist and immunologist. He won the 2018 Nobel Prize in Physiology or Medicine and is best known for his identification of programmed cell death protein 1 (PD-1).

A life in dates

2021Honorary Doctor of the Aix-Marseille UniversityAward2018Nobel Prize in Physiology or MedicineAward2017Warren Alpert Foundation PrizeAward2016Clarivate Citation LaureatesAwardKeio Medical Science PrizeAwardKyoto Prize in Basic SciencesAward2014Tang PrizeAwardWilliam B. Coley AwardAward2013Order of CultureAward2012Robert Koch PrizeAward2000Person of Cultural MeritAward1996Imperial Prize of Japan AcademyAward1981Asahi PrizeAward1942Born27 January 1942

Also in Deutsch

Photos 5

Awards

Honorary Doctor of the Aix-Marseille University2021
Nobel Prize in Physiology or Medicine2018
Warren Alpert Foundation Prize2017
Keio Medical Science Prize2016
Kyoto Prize in Basic Sciences2016
Clarivate Citation Laureates2016
Tang Prize2014
William B. Coley Award2014
Order of Culture2013
Robert Koch Prize2012
Person of Cultural Merit2000
Imperial Prize of Japan Academy1996
Asahi Prize1981

About this person

Tasuku Honjo is a Japanese physician-scientist and immunologist. He won the 2018 Nobel Prize in Physiology or Medicine and is best known for his identification of programmed cell death protein 1 (PD-1). He is also known for his molecular identification of cytokines IL-4 and IL-5, as well as the discovery of activation-induced cytidine deaminase (AID) that is essential for class switch recombination and somatic hypermutation.

Country
Japan
Category
Academics
Type
Academic
Status
living
Dates
Born 1942 · age 84

Fame.am measures public visibility signals. It does not measure human value, talent, morality, or credibility.